See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Johnson and Johnson Archives

Johnson and Johnson Article Archives

February 2013

Mike Fisher, Competitive Snowboarder

Mike Fisher is a 23-year-old from Ontario, Canada, who's been snowboarding since he was 13 years old. At the age of 18, he was involved in a motorcycle crash that necessitated the amputation of one leg below the knee. He says, "At first, I felt that my life was coming to a crashing halt. But I just pushed myself to recover as fast as possible and get my life back on track, go to school, get back into snowboarding and motorcycles-just anything so that my life wasn't affected at all. I had a lot of support, and I would say that I was pretty optimistic about it and took it almost as a challenge. By the time that I was 19, I was happy. I was walking again, I was back in college in London, Ontario, and everything was good. The accident was a minor setback to me, and I rose above it. I was just continuing with my life."

comments 8 comments - Posted Feb 2, 2013

Type 2: FDA OKs Canagliflozin But Has Concerns About Heart Risk

In a 10-5 vote, an FDA panel has recommended that the agency approve the marketing of Johnson & Johnson's InvokanaTM (canagliflozin), an oral once-daily drug for treating type 2 diabetes in adults.

comments 0 comments - Posted Feb 1, 2013

January 2012

Animas Receives Warning Letter From the FDA

Animas Corporation, a division of Johnson & Johnson that manufactures insulin pumps, has been reprimanded by the FDA for not reporting serious problems resulting from use of its equipment. The parent company was warned that it could face fines and more for selling faulty insulin pumps and failing to disclose serious injuries to diabetic patients who used the OneTouch Ping and 2020 insulin pumps. According to reports, J&J continued to sell the pumps even after the company knew that some had failed.

comments 1 comment - Posted Jan 29, 2012

May 2011

As LifeScan-Medtronic Exclusivity Pact Ends, Medtronic Expands Alliance With Bayer

U.S. insulin pump maker Medtronic and blood glucose monitoring system maker LifeScan have reached the end of their three-year contract in which LifeScan was an exclusive provider to Medtronic.

comments 1 comment - Posted May 29, 2011

April 2011

Chase Pelletier, Competitive Kart Racer

Chase Pelletier is an up-and-coming kart racer from Canada who is 14 years old. When he got type 1 diabetes just before his eleventh birthday, he recalls, "It was pretty overwhelming at first. But me and my family decided early on that we're not going to get down on diabetes in general, and we're going to try to think of positive ways to deal with it."

comments 0 comments - Posted Apr 28, 2011

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.